ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,018.39
-0.34%
US Tech 100
16,952.00
-0.19%
다우존스 지수
37,903.29
0.23%
Bitcoin
57,630.44
-1.04%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Maravai LifeSciences Holdings Inc (MRVI)

  7. Maravai LifeSciences Holdings Inc (MRVI) 뉴스

MRVI Maravai LifeSciences Holdings Inc

8.42
0.22 (2.68%)
02 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Maravai LifeSciences Holdings Inc MRVI 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.22 2.68% 8.42 08:48:32
개장가 저가 고가 종가 전일 종가
8.23 8.13 8.74 8.42 8.20
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202405:49BWTriLink BioTechnologies® et Lonza signent un contrat de..
30/04/202420:31BWTriLink BioTechnologies® and Lonza Enter into Non-exclusive..
19/04/202404:12BWTriLink BioTechnologies® annonce un nouveau site à San Diego..
19/04/202404:09BWTriLink BioTechnologies® kündigt neue Anlage in San Diego..
18/04/202420:36BWTriLink BioTechnologies® Announces New San Diego Facility..
11/04/202405:05GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
13/03/202405:15GLOBEMaravai LifeSciences Announces March 2024 Investor..
01/03/202407:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/02/202406:08EDGAR2Form 8-K - Current report
23/02/202406:05GLOBEMaravai LifeSciences Reports Fourth Quarter and Full Year..
21/02/202422:00BWTriLink BioTechnologies® Solidifies IP Position with Awarded..
21/02/202408:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202422:30GLOBEDyadic and Cygnus Technologies Announce Partnership To..
09/02/202406:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29/01/202422:00GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
19/01/202408:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202408:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202408:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202408:15EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
17/11/202307:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:15GLOBEMaravai LifeSciences Announces November 2023 Investor..
09/11/202307:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202306:11EDGAR2Form 8-K - Current report
08/11/202306:05GLOBEMaravai LifeSciences Reports Third Quarter 2023 Financial..
02/11/202319:47BWTriLink BioTechnologies® Expands Capabilities with Launch of..
18/10/202306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202321:15GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
29/09/202321:15GLOBEMaravai LifeSciences Hosts 2023 Investor R&D Day
19/09/202322:31GLOBEMaravai LifeSciences Chief Innovation Officer Kate Broderick..
06/09/202305:15GLOBEMaravai LifeSciences to Host 2023 Investor R&D Day
23/08/202321:15GLOBECygnus Technologies Receives 2023 R&D 100 Award for MockV®..
23/08/202305:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/08/202305:15GLOBEMaravai LifeSciences Announces August 2023 Investor..
09/08/202305:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202305:19EDGAR2Form 8-K - Current report
08/08/202305:05GLOBEMaravai LifeSciences Reports Second Quarter 2023 Financial..
28/07/202305:11EDGAR2Form 8-K - Current report
28/07/202305:05GLOBEMaravai LifeSciences Announces Completion of Planned CEO..
25/07/202305:05GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
21/07/202305:08EDGAR2Form 8-K - Current report
21/07/202305:05GLOBEMaravai LifeSciences Announces Appointment of New Director..
20/07/202305:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/07/202305:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/07/202305:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/07/202305:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/07/202305:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/07/202305:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/06/202321:00GLOBECongressman Scott Peters Tours Maravai’s RNA manufacturing..
25/05/202305:58BWトライリンク・バイオテクノロジーズ®が製造能力拡張を発表、mRNA製造施設が完成間近

최근 히스토리

NASDAQ
MRVI
Maravai LifeSciences
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유